| A small-molecule inhibitor of the aberrant transcription factor CBFβ-SMMHC delays leukemia in mice A Illendula, JA Pulikkan, H Zong, J Grembecka, L Xue, S Sen, Y Zhou, ... Science 347 (6223), 779-784, 2015 | 126 | 2015 |
| Amberlyst-15®: a novel and recyclable reagent for the synthesis of 1, 5-benzodiazepines in ionic liquids JS Yadav, BVS Reddy, B Eshwaraiah, K Anuradha Green Chemistry 4 (6), 592-594, 2002 | 126 | 2002 |
| Small molecule inhibitor of CBFβ-RUNX binding for RUNX transcription factor driven cancers A Illendula, J Gilmour, J Grembecka, VSS Tirumala, A Boulton, ... EBioMedicine 8, 117-131, 2016 | 118 | 2016 |
| RUNX1-targeted therapy for AML expressing somatic or germline mutation in RUNX1 CP Mill, W Fiskus, CD DiNardo, Y Qian, K Raina, K Rajapakshe, D Perera, ... Blood, The Journal of the American Society of Hematology 134 (1), 59-73, 2019 | 93 | 2019 |
| CBFβ-SMMHC inhibition triggers apoptosis by disrupting MYC chromatin dynamics in acute myeloid leukemia JA Pulikkan, M Hegde, HM Ahmad, H Belaghzal, A Illendula, J Yu, ... Cell 174 (1), 172-186. e21, 2018 | 89 | 2018 |
| Solid-phase synthesis of 1, 4-diketones by thiazolium salt promoted addition of aldehydes to chalcones S Raghavan, K Anuradha Tetrahedron letters 43 (29), 5181-5183, 2002 | 74 | 2002 |
| RUNX1 is required for oncogenic Myb and Myc enhancer activity in T-cell acute lymphoblastic leukemia AH Choi, A Illendula, JA Pulikkan, JE Roderick, J Tesell, J Yu, ... Blood, The Journal of the American Society of Hematology 130 (15), 1722-1733, 2017 | 72 | 2017 |
| Solid-phase synthesis of heterocycles from 1, 4-diketone synthons S Raghavan, K Anuradha Synlett 2003 (05), 0711-0713, 2003 | 65 | 2003 |
| RUNX proteins desensitize multiple myeloma to lenalidomide via protecting IKZFs from degradation N Zhou, A Gutierrez-Uzquiza, XY Zheng, R Chang, DT Vogl, AL Garfall, ... Leukemia 33 (8), 2006-2021, 2019 | 58 | 2019 |
| Biocatalysis of the Antimalarial Artemisinin by Mucor ramannianus. Strains IA Parshikov, B Miriyala, KM Muraleedharan, A Illendula, MA Avery, ... Pharmaceutical biology 43 (7), 579-582, 2005 | 42 | 2005 |
| Microwave-accelerated conjugate addition of aldehydes to α, β-unsaturated ketones JS Yadav, K Anuradha, BVS Reddy, B Eeshwaraiah Tetrahedron letters 44 (50), 8959-8962, 2003 | 38 | 2003 |
| NOXA expression drives synthetic lethality to RUNX1 inhibition in pancreatic cancer J Doffo, SA Bamopoulos, H Köse, F Orben, C Zang, M Pons, ... Proceedings of the National Academy of Sciences 119 (9), e2105691119, 2022 | 23 | 2022 |
| Small molecule inhibition of the CBFβ/RUNX interaction decreases ovarian cancer growth and migration through alterations in genes related to epithelial-to-mesenchymal transition AL Carlton, A Illendula, Y Gao, DC Llaneza, A Boulton, A Shah, ... Gynecologic oncology 149 (2), 350-360, 2018 | 21 | 2018 |
| Synthesis and biological activity of some new heterocyclic annelated compounds from 2,3,4,5-tetrahydro-1-benzazepines V Peesapati, K Anuradha Indian Journal of Chemistry, Section B: Organic Chemistry Including …, 1996 | 18 | 1996 |
| Inhibition of the RUNX1-CBFβ transcription factor complex compromises mammary epithelial cell identity: a phenotype potentially stabilized by mitotic gene bookmarking JT Rose, E Moskovitz, JR Boyd, JA Gordon, NA Bouffard, AJ Fritz, ... Oncotarget 11 (26), 2512, 2020 | 17 | 2020 |
| A tool compound targeting the core binding factor Runt domain to disrupt binding to CBFβ in leukemic cells ZM Oo, A Illendula, J Grembecka, C Schmidt, Y Zhou, V Esain, W Kwan, ... Leukemia & lymphoma 59 (9), 2188-2200, 2018 | 14 | 2018 |
| Nanoliposome C6‐Ceramide in combination with anti‐CTLA4 antibody improves anti‐tumor immunity in hepatocellular cancer X Qi, F Wu, SH Kim, JT Kaifi, ET Kimchi, H Snyder, A Illendula, T Fox, ... The FASEB Journal 36 (4), 2022 | 11 | 2022 |
| Determination of antimalarial compound, ARB-89 (7β-hydroxy-artemisinin carbamate) in rat serum by UPLC/MS/MS and its application in pharmacokinetics D Pabbisetty, A Illendula, KM Muraleedharan, AG Chittiboyina, ... Journal of Chromatography B 889, 123-129, 2012 | 11 | 2012 |
| Regulome analysis in B-acute lymphoblastic leukemia exposes Core Binding Factor addiction as a therapeutic vulnerability JP Wray, EM Deltcheva, C Boiers, SЕ Richardson, JB Chhetri, J Brown, ... Nature Communications 13 (1), 7124, 2022 | 10 | 2022 |
| Synthesis and Antimicrobial Activity of New Thiazolo/Thiazinopyrimidino [6, 5-C] Benzocycloheptenes V Peesapati, K Anuradha, P Sreelakshmi Synthetic Communications 29 (24), 4381-4395, 1999 | 9 | 1999 |
